In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and Medicare.
If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.